NFKB1 and cancer: Apigenin has been reported to target multiple signaling pathways, such as PI3K/Akt/mTOR, MAPK/ERK, JAK/STAT, NF-kB, and Wnt/β-catenin pathways, involved in the development and progression of cancer.